Suppr超能文献

经皮冠状动脉介入治疗使用带药物洗脱支架的全金属护套:一年时的主要不良心脏事件。

Percutaneous coronary intervention using a full metal jacket with drug-eluting stents: major adverse cardiac events at one year.

出版信息

Arq Bras Cardiol. 2013 Aug;101(2):117-26. doi: 10.5935/abc.20130139. Epub 2013 Jul 2.

Abstract

BACKGROUND

The clinical benefit of percutaneous coronary intervention (PCI) for long coronary lesions is unclear; furthermore, concerns have been raised about its safety.

OBJECTIVES

To evaluate the predictors of major adverse cardiac events (MACE) associated with PCI using a full metal jacket (FMJ), defined as overlapping drug-eluting stents (DES) measuring >60 mm in length, for very long lesions.

METHODS

We enrolled 136 consecutive patients with long coronary lesions requiring FMJ in our single-center registry. The primary endpoint included the combined occurrence of all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR). Demographic, clinical, angiographic, and procedural variables were evaluated using stepwise Cox regression analysis to determine independent predictors of outcome.

RESULTS

The mean length of stent per lesion was 73.2 ± 12.3 mm and the mean reference vessel diameter was 2.9 ± 0.6 mm. Angiographic success was 96.3%. Freedom from MACE was 94.9% at 30 days and 85.3% at one year. At the one-year follow-up, the all-cause mortality rate was 3.7% (1.5% cardiac deaths), the MI rate was 3.7%, and the incidence of definite or probable stent thrombosis (ST) was 2.9%. Female gender [hazard ratio (HR), 4.40; 95% confidence interval (CI), 1.81-10.66; p = 0.001) and non-right coronary artery PCI (HR, 3.49; 95%CI, 1.42-8.59; p = 0,006) were independent predictors of MACE at one year. Freedom from adverse events at one year was higher in patients with stable angina who underwent PCI (HR, 0.33; 95%CI, 0.13-0.80; p = 0.014).

CONCLUSIONS

PCI using FMJ with DES for very long lesions was efficacious but associated with a high rate of ST at the one-year follow-up. However, the rate of cardiac mortality, nonprocedure-related MI, and MACE was relatively low. Target coronary vessel PCI, clinical presentation, and female gender are new contemporary clinical factors that appear to have adverse effects on the outcome of PCI using FMJ for long lesions.

摘要

背景

经皮冠状动脉介入治疗(PCI)治疗长段冠状动脉病变的临床获益尚不清楚,而且人们对其安全性也存在担忧。

目的

评估使用全金属护套(FMJ)治疗超长病变的 PCI 后主要不良心脏事件(MACE)的预测因素,FMJ 定义为重叠药物洗脱支架(DES)长度超过 60mm。

方法

我们在单中心注册研究中纳入了 136 例需要 FMJ 的长段冠状动脉病变患者。主要终点包括全因死亡、心肌梗死(MI)和靶血管血运重建(TVR)的联合发生。使用逐步 Cox 回归分析评估人口统计学、临床、血管造影和手术变量,以确定结局的独立预测因素。

结果

平均每个病变的支架长度为 73.2±12.3mm,平均参考血管直径为 2.9±0.6mm。血管造影成功率为 96.3%。30 天无 MACE 发生率为 94.9%,1 年无 MACE 发生率为 85.3%。在 1 年随访时,全因死亡率为 3.7%(1.5%为心源性死亡),MI 发生率为 3.7%,明确或可能的支架血栓形成(ST)发生率为 2.9%。女性(危险比[HR],4.40;95%置信区间[CI],1.81-10.66;p=0.001)和非右冠状动脉 PCI(HR,3.49;95%CI,1.42-8.59;p=0.006)是 1 年时 MACE 的独立预测因素。稳定性心绞痛患者行 PCI 后 1 年无不良事件发生率更高(HR,0.33;95%CI,0.13-0.80;p=0.014)。

结论

使用 FMJ 和 DES 治疗超长病变的 PCI 是有效的,但在 1 年随访时 ST 的发生率较高。然而,心脏死亡率、非手术相关 MI 和 MACE 的发生率相对较低。靶血管 PCI、临床表现和女性是影响使用 FMJ 治疗长病变 PCI 结局的新的当代临床因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验